Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype

Seminars in Oncology

Volumn 41, Issue 2, 2014, Pages 252-258

  Carr, Brian I ^a   Guerra, Vito ^a   Giannini, Edoardo G ^b   Farinati, Fabio ^c   Ciccarese, Francesca ^d   Ludovico Rapaccini, Gian ^e   Di Marco, Maria ^f   Benvegnù, Luisa ^c   Zoli, Marco ^g   Borzio, Franco ^h   Caturelli, Eugenio ⁱ   Chiaramonte, Maria ^j   Trevisani, Franco ^g  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Presidio Ospedaliero   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f BOLOGNINI HOSPITAL   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h FATEBENEFRATELLI HOSPITAL   (Italy)

ⁱ BELCOLLE HOSPITAL   (Italy)

^j SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

AGGRESSIVENESS; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; ITALY; LIVER; LIVER NEOPLASMS; LOGISTIC MODELS; ODDS RATIO; PHENOTYPE; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84899705370     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.03.006     Document Type: Article

References (20)

1. K. Okuda, T. Ohtsuki, and H. Obata et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment Cancer 56 1985 918 928
2. Cancer of the Liver Italian Programme (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751 755
3. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
4. A. Grieco, M. Pompili, G. Caminiti, L. Miele, M. Covino, and B. Alfei et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre Gut 54 2005 411 418
5. R. Tateishi, H. Yoshida, S. Shiina, H. Imamura, K. Hasegawa, and T. Teratani et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 2005 419 425
6. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 664
7. A. Kinoshita, H. Onoda, N. Imai, A. Iwaku, M. Oishi, and K. Tanaka et al. The Glasgow prognostic score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma BMC Cancer 13 2013 52
8. D.J. Pinato, J. Stebbing, M. Ishizuka, S.A. Khan, H.S. Wasan, and B.V. North et al. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI) J Hepatol 57 2012 1013 1020
9. B.I. Carr, S.C. Buch, V. Kondragunta, P. Pacoska, and R.A. Branch Tumor and liver determinants of prognosis in unresectable HCC: a case cohort study J Gastroenterol Hepatol 23 2008 1259 1266
10. B.I. Carr, V. Guerra, and P. Pancoska Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma Oncology 83 2012 339 345
11. V. Santi, D. Buccione, A. Di Micoli, G. Fatti, M. Frigerio, and F. Farinati et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy J Hepatol 56 2012 397 405
12. M. Minagawa, and M. Makuuchi Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 2006 7561 7567
13. K. Okuda, T. Nakashima, and M. Kojiro et al. Hepatocellular carcinoma without cirrhosis in Japanese patients Gastroenterology 97 1989 140 146
14. F. Trevisani, P.E. D'Intino, and P. Caraceni et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients Cancer 75 1995 2220 2232
15. B.I. Carr, and V. Guerra Features of massive hepatocellular carcinomas Eur J Gastroenterol Hepatol 26 2014 101 108
16. S.D. Wu, Y.S. Ma, Y. Fang, L.L. Liu, D. Fu, and X.Z. Shen Role of the micro-environment in hepatocellular carcinoma development and progression Cancer Treat Rev 38 2012 218 225
17. J.D. Yang, I. Nakamura, and L.R. Roberts The tumor micro-environment in hepatocellular carcinoma: current status and therapeutic targets Semin Cancer Biol 21 2011 35 43
18. V. Hernandez-Gea, S. Toffanin, S.L. Friedman, and J.M. Llovet Role of the micro-environment in the pathogenesis and treatment of hepatocellular carcinoma Gastroenterology 144 2013 512 527
19. B.I. Carr And Guerra V.HCC and its microenvironment Hepatogastroenterology 60 2013 1433 1437
20. P. Pancoska, B.I. Carr, and R.A. Branch Network-based analysis of survival for unresectable hepatocellular carcinoma Semin Oncol 37 2010 170 181